An AI tool accurately detected structural heart disease from smartwatch single-lead ECGs in a 600-person prospective trial.
Key Details
- 1AI model was trained using 266,000 12-lead ECGs from 110,000 patients and validated on large external cohorts.
- 2Prospective real-world testing was performed with 600 adults using smartwatch-recorded single-lead ECGs.
- 3Algorithm achieved 88% accuracy (AUC) in smartwatch data; sensitivity was 86% and negative predictive value 99%.
- 4Diseases detected included weakened pumping, valve damage, or thickened heart muscle—most commonly found with cardiac ultrasound (echo).
- 5Preliminary results were presented at AHA Scientific Sessions 2025 and have not yet been peer-reviewed.
Why It Matters
Wearable devices leveraging AI may democratize early detection of serious heart conditions, traditionally requiring advanced imaging. This signals a potential paradigm shift in accessible screening workflows, informing radiology and cardiology practice.
Source
EurekAlert
Related News
•EurekAlert
AI Knowledge Graph Boosts Decision Support in Recurrent Pregnancy Loss
A novel graph-based AI system, RSA-KG, significantly improves clinical decision support for diagnosing recurrent spontaneous abortion (RSA) by integrating multimodal clinical data and expert guidelines.
•EurekAlert
MAGIC AI System Enables High-Throughput Cancer Cell Imaging and Analysis
Researchers developed MAGIC, an AI-based system integrating automated microscopy and genomics to study chromosomal abnormalities linked to cancer.
•EurekAlert
AI Accelerates Solid Tumor Drug Development and Personalized Oncology
AI is expediting the timeline and personalization of solid tumor drug development using multi-omics, imaging, and advanced computational models.